BackTable Urology

Are you interested in building an academic niche within global surgery? Dr. Catherine deVries, Professor of Urology and Global Surgery at the University of Utah and founder of International Volunteers in Urology (IVUMed), shares her journey and provides a blueprint for the aspiring academic surgeon. This episode is hosted by Dr. Suzette Sutherland in collaboration with the Society of Women in Urology.

---

This podcast is supported by:

Boston Scientific UroAdvance

http://bostonscientific.com/uroadvance

---

SYNPOSIS

The episode focuses on Dr. deVries experiences as a groundbreaking woman in the historically male-dominated field of urology. Dr. deVries delves into her landmark contributions to global health, particularly through her work leading IVUMed. She shares her experiences developing sustainable surgical care programs and her academic journey. The conversation also touches on the importance of ethics and public health when conducting surgical missions. The discussion serves as an inspiration for future generations in the field of urology and global health.

---

TIMESTAMPS

00:00 - Introduction

02:17 - Dr. DeVries' Academic and Professional Journey

04:08 - Experiences as a Woman in Urology

14:55 - Pediatric Urology and Global Health

21:54 - Founding IVUMed

40:34 - Future Directions

44:14 - Conclusion

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/urology/products.html

Society of Women in Urology

https://swiu.org/home.aspx

We are excited to introduce a new collaboration with the Society of Women in Urology (SWIU)! In this episode of BackTable Urology, guest host Dr. Casey Seideman discusses the impact of SWIU with society leadership Dr. Akanksha Mehta and Dr. Simone Thavaseelan.

---

This podcast is supported by:

Boston Scientific UroAdvance

http://bostonscientific.com/uroadvance

---

SYNPOSIS

The doctors talk about SWIU's rapid growth, its role in networking and career development for women, and its proven impact across career stages. They highlight the importance of the annual Clinical Mentoring Conference, which provides a unique opportunity for networking and professional development. The conversation also underscores SWIU's inclusivity and efforts for gender-diverse individuals. Looking ahead, Dr. Mehta and Dr. Thavaseelan predict continued growth, innovation, and deeper integration in organized urology.

---

TIMESTAMPS

00:00 - Introduction

02:42 - History of SWIU

03:29 - Personal Journeys with SWIU

07:08 - The Mentoring Conference

09:27 - Career Development

34:40 - Inclusivity and Male Allyship

39:14 - Conclusion

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/urology/products.html

Society of Women in Urology

https://swiu.org/home.aspx

What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable Urology Podcast, Dr. Rana McKay, a medical oncologist from UC San Diego, joins host Dr. Aditya Bagrodia to discuss the administration of ADT and other management strategies for prostate cancer.

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

The doctors offer a historical perspective into the evolution of ADT over time and discuss the variety of different ADT treatment options available. They compare management strategies for localized and metastatic prostate cancer and discuss how to align therapy with patient goals, focusing on the side effects. The conversation also explores the impact of prostate-specific membrane antigen (PSMA) PET imaging on management and the future directions of hormonal therapies in urologic oncology.

---

TIMESTAMPS

00:00 - Introduction

05:25 - ADT Options

10:36 - Choosing an Agent and Managing Side Effects

26:42 - Continuous Versus Intermittent Therapy

30:30 - Closing Remarks

---

RESOURCES

Photocure

https://www.photocure.com/

Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting.

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.

---

TIMESTAMPS

00:00 - Introduction

04:47 - Community Practice and New Technologies

09:59 - Clinical Trials for Bladder Cancer Care

15:52 - Patient Referrals

29:27 - Exploring New Treatment Options

30:46 - Bladder Sparing Strategies

32:21 - BCG Treatment and Surveillance

47:04 - Implementation of New Therapies

54:27 - Future Directions

---

RESOURCES

Ferring Pharmaceuticals

https://www.ferring.com/

If you manage a busy men’s health practice, you may have considered the value of staffing Advanced Practice Providers (APPs). In this episode of BackTable Urology, Dr. Alex Tatem and Kristen Gumpf, PA-C join host Dr. Jose Silva to discuss the role of APPs in men’s health.

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Their discussion highlights the rewarding experience in seeing patients throughout their treatment journey. Dr. Tatem, a men's health specialist with an extensive academic background, emphasizes the value of integrating APPs like Kristen into his practice. Kristen shares her journey, highlighting the importance of continuous learning. Both share their personal stories on the early days and evolution of their partnership. The conversation delves into the dynamics of their successful clinic model, the impact of their work on patient care, and their plans for expanding and educating within the field of men's health.

---

TIMESTAMPS

00:00 - Introduction

05:10 - Kristen's Path to Specialization

17:42 - Redefining Roles and Responsibilities

28:00 - Work-Life Balance

31:12 - Office Procedures

34:35 - Expanding the Team

47:26 - Team Dynamics

54:18 - Concluding Thoughts

---

RESOURCES

Dr. Alex Tatem’s practice website:

https://www.alextatemmd.com/

APP Fellowship Program in Indianapolis, Indiana:

https://menshealthin.com/training/

2024 Prosthetic Urology Institute: Advanced Practice Provider Preceptor Program - Kristen Gumpf, PA-C:

https://cvent.me/mNE3ly

2024 Prosthetic Urology Institute: Preceptor and Clinic Communications Program with Dr. Alex Tatem:

https://cvent.me/1ZKdEq

How can urologists run clinical trials efficiently while improving enrollment and reducing costs? In this episode of the BackTable Urology Podcast, Dr. Behfar Ehdaie, a urologic oncologist at Memorial Sloan Kettering Cancer Center, joins host Dr. Aditya Bagrodia to discuss methods and practical implementation strategies for clinical trials in urology.

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

First, Dr. Ehdaie shares personal experiences from starting pilot trials, engaging stakeholders, and integrating trial processes into clinical practice. He also discusses mechanisms to reduce cost and improve enrollment while explaining the concept of two-stage consent to minimize patient anxiety. This episode aims to provide valuable pearls for young investigators and experienced practitioners alike on conducting successful clinical trials.

---

TIMESTAMPS

00:00 - Introduction

04:39 - Challenges in Clinical Trials

06:21 - Case Study: Focal Therapy Trial

16:45 - Case Study: Hernia Trial

20:17 - Innovation in Clinical Trials

26:25 - Two-Stage Consent

36:11 - Final Thoughts

---

RESOURCES

Photocure

https://www.photocure.com/

Have you checked out the AUA/ASTRO/SUO’s recently released guidelines for salvage therapy in prostate cancer biochemical recurrence? In this episode of the BackTable Urology Podcast, guest Dr. Todd Morgan from the University of Michigan and host Dr. Aditya Bagrodia continue with part two of our series on prostate cancer biochemical recurrence management.

---

This podcast is supported by:

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

The doctors focus on the difficulty in declaring a patient 'cured' and the implications of biochemical recurrence after treatment. Dr. Morgan highlights the importance of PSA in the postoperative setting and explores the role of the Decipher Prostate Genomic Classifier in personalizing treatment. He talks through the latest AUA/ASTRO/SUO consensus on biochemical recurrence guidelines, including the significance of early salvage therapy and the integration of advanced imaging techniques like PSMA PET scans. Further, Dr. Morgan emphasizes the role for multidisciplinary evaluation, patient counseling, and future directions of research to refine treatment options.

This discussion underscores the transition from adjuvant to early salvage radiation as a standard practice and considers emerging biomarker strategies to inform treatment decisions.

---

TIMESTAMPS

00:00 - Introduction

03:41 - Consensus Biochemical Recurrence Guidelines

08:56 - Evolution of Post-Prostatectomy Biochemical Recurrence Management

13:24 - Patient Counseling and Risk of Recurrence

17:42 - PSMA PET Scans

20:44 - Postoperative PSA Monitoring

28:35 - The Role of Radiation

31:56 - Hormone Therapy

39:00 - Salvage Lymphadenectomy

46:30 - Future Directions and Concluding Thoughts

---

RESOURCES

Veracyte

https://www.veracyte.com/

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline (2024)

https://www.auanet.org/guidelines-and-quality/guidelines/salvage-therapy-for-prostate-cancer

While benign prostatic hyperplasia (BPH) care has historically focused on immediate symptom management, often by way of long-term polypharmacy, leading urologists are now considering long-term bladder health when determining the most appropriate BPH treatment. In this episode of the BackTable Urology Podcast, Dr. Shawn West, a urologist practicing at McIver Clinic in Florida, discusses the contemporary management of BPH with host Dr. Jose Silva, emphasizing the newly appreciated role of first-line interventional therapy.

---

This podcast is supported by:

Teleflex UroLift

https://www.urolift.com/

---

SYNPOSIS

First, Dr. West delves into the initial patient consultation, diagnostic procedures, and the diverse treatment options for BPH including UroLift, GreenLight laser therapy, and Aquablation. Dr. West emphasizes the importance of individualized patient care, the role of objective symptom scoring systems, and the significance of setting realistic expectations for patients. The discussion also covers the benefits and challenges of different BPH treatments amidst the evolving landscape of minimally invasive urological procedures.

---

TIMESTAMPS

00:00 - Introduction

03:59 - BPH and Voiding Dysfunction

10:21 - Patient-Centered Approach to BPH

19:46 - Diagnostic Workup for BPH

24:53 - Postoperative Catheter and Complications

25:02 - Aquablation

26:04 - UroLift

31:06 - Challenges with Median Lobes

41:02 - Postoperative Care

47:14 - Conclusion

Stay up to date in your bladder cancer practice with this insightful episode of the BackTable Urology podcast, developed in collaboration with the Society of Urologic Oncology. Dr. Betsy Koehne (University of Wisconsin) and Dr. Amir Salmasi (UC San Diego) talk through the contemporary management of low and intermediate-risk non-muscle-invasive bladder cancer.

---

SYNPOSIS

The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments.

---

TIMESTAMPS

00:00 - Introduction

01:51 - Initial Consultation

08:01 - TURBT Procedure Insights

23:14 - Managing Low and Intermediate Risk Bladder Cancer

26:47 - Recurrence and Surveillance Strategies

27:48 - Prognostication Tools

30:10 - Intravesical Chemotherapy Options

33:24 - High Grade Tumors

42:33 - Clinical Trials and Emerging Therapies

49:19 - Concluding Thoughts

Recent research is changing how we manage low risk prostate cancer. In this BackTable Urology Podcast episode, Dr. Dan Lin, a urologist at the University of Washington, walks through contemporary diagnosis, surveillance, and management of Grade Group 2 prostate cancer with host Dr. Aditya Bagrodia.

---

This podcast is supported by:

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

The doctors delve into real-world implementation of active surveillance, alongside the use of advanced diagnostics, biopsy methods, and personalized care plans. The conversation highlights the Canary Prostate Active Surveillance Study (PASS) and the prognostic role of biomarkers and genomic testing. Dr. Lin and Dr. Bagrodia also discuss how lifestyle factors such as diet impact cancer progression and how patients can be empowered to manage their disease. Strategies for transitioning patients off surveillance are highlighted. Finally, the two experts discuss insights from recent clinical trials like PIVOT, PROTECT, and SPCG and how they’re impacting prostate cancer management.

---

TIMESTAMPS

00:00 - Introduction

02:54 - Active Surveillance and Canary PASS Data

12:02 - Biopsy Considerations

19:44 - Active Surveillance Protocols

26:58 - Patient Concerns and Risk Reduction

30:52 - Transitioning Off Surveillance

33:39 - Grade Group 2: Treatment vs. Monitoring

46:24 - Surgical Considerations and Node Dissection

49:25 - Future Directions

---

RESOURCES

Veracyte

https://www.veracyte.com/